Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Treating hearing sits at the center of this dementia and brain health question.
Treating hearing loss matters more than medication for brain health because it addresses one of the most preventable causes of cognitive decline and dementia—a problem that affects far more people than we typically realize. According to the Lancet Commission on Dementia, hearing loss accounts for the greatest number of potentially preventable cases of dementia, yet it remains dramatically underdiagnosed and undertreated. While pharmaceutical interventions continue to be explored and promoted for cognitive health, the evidence for hearing aid use in slowing cognitive decline is now so compelling that it rivals or exceeds what we see with many medications currently prescribed to prevent dementia. Consider the case of Margaret, a 72-year-old who noticed her memory seemed to be slipping. She was struggling to follow conversations at family dinners and had withdrawn from book club.
Her doctor prescribed a memory-boosting medication, but the real problem wasn’t her hippocampus—it was her hearing. Once she got hearing aids, she re-engaged socially, stopped straining cognitively to process sound, and within months her family noticed her memory felt sharper. Margaret’s story is not unusual. Approximately 65% of adults over age 60 have hearing loss, yet fewer than a third seek treatment. The barrier isn’t the effectiveness of hearing aids; it’s awareness that hearing loss is a modifiable risk factor for dementia at all.
Table of Contents
- How Does Hearing Loss Increase Your Risk of Cognitive Decline and Dementia?
- Why Hearing Loss Is a Modifiable Risk Factor—Unlike Many Genetic Risks
- The ACHIEVE Study and Hearing Aids’ Real Impact on Cognitive Decline
- The Timing Problem: Why Early Treatment Beats Years of Waiting
- The Medication Trap: Why We’ve Been Looking in the Wrong Direction
- Real-World Implementation: The Difference Between “Getting” Hearing Aids and Actually Using Them
- The Future of Prevention: What Hearing Loss Detection Means for Brain Health
- Conclusion
How Does Hearing Loss Increase Your Risk of Cognitive Decline and Dementia?
The research is unambiguous: adult-onset hearing loss significantly increases your risk for cognitive decline, mild cognitive impairment (MCI), and Alzheimer’s disease. A 2024 meta-analysis examining 50 studies with over 1.5 million participants found consistent associations between hearing loss and multiple forms of cognitive impairment. The University of Southern Denmark tracked 573,088 people and found that hearing loss increases dementia risk by 7%—a substantial increase when applied to entire populations. The mechanism is worth understanding because it illustrates why hearing loss isn’t just an ear problem.
When your brain can’t process sound clearly, it divert substantial cognitive resources to compensate—struggling to fill in gaps, trying harder to understand speech, and working overtime to extract meaning from degraded acoustic input. That’s energy diverted from memory formation, executive function, and the cognitive processes that protect against decline. Over years or decades, this constant compensatory effort may contribute to accelerated cognitive aging. This isn’t speculation; it’s the leading explanation supported by neuroscience research examining how the brain allocates its limited processing capacity.
Why Hearing Loss Is a Modifiable Risk Factor—Unlike Many Genetic Risks
What makes hearing loss unique among dementia risk factors is that it’s actually reversible through intervention. You cannot change your genetics. You cannot undo decades of cardiovascular stress. But you can treat hearing loss. This fundamental difference explains why the Lancet Commission specifically identified hearing loss as the single most impactful, preventable dementia risk factor in their analysis of lifestyle and modifiable factors.
However, there’s an important limitation here: not everyone with hearing loss who receives hearing aids experiences the same cognitive benefit. The effectiveness depends partly on when you start treatment, how consistently you use the hearing aids, and the severity of your baseline hearing loss. Additionally, hearing aids don’t work overnight. They require a period of adjustment—both neurologically as your brain reprocesses clearer sound, and psychologically as you adjust to wearing them. Some people report an initial period of overwhelm as they suddenly hear sounds they’ve been missing, which can be disorienting until the brain recalibrates.
The ACHIEVE Study and Hearing Aids’ Real Impact on Cognitive Decline
The most compelling evidence comes from the ACHIEVE study, the largest randomized controlled trial examining whether hearing aid use can slow cognitive decline. Adults at increased risk for cognitive decline who received hearing aids showed a nearly 48% slowing of cognitive decline over 3 years compared to a control group. Let that number sit for a moment: a nearly 50% reduction in the rate of cognitive decline. For context, many pharmaceutical interventions being studied for dementia prevention show effect sizes substantially smaller than this.
Additional research from Johns Hopkins found that among those with hearing loss, those using hearing aids had a 32% lower prevalence of dementia when they had moderate or severe hearing loss. Among participants under 70 at the time of diagnosis, those with hearing aids had a 61% lower risk for incident all-cause dementia—a dramatic protective effect. In another analysis, 36% of those prescribed hearing aids developed cognitive impairment over the study period, compared with 42% of those without hearing aids, representing a 15% relative risk reduction. These aren’t marginal improvements; they’re clinically significant changes in outcomes.
The Timing Problem: Why Early Treatment Beats Years of Waiting
One of the most important findings that hasn’t yet reached mainstream awareness is the critical window for intervention. Research following 2,089 participants over 25 years found that early hearing aid adoption—specifically, treatment within 3 years of diagnosis—provided significantly better cognitive protection than delayed treatment. If you’re diagnosed with hearing loss but wait 10 years before getting hearing aids, your brain has already adapted to (and suffered from) a decade of compensatory stress.
This timing issue illuminates a critical weakness in how we currently approach brain health: we often treat the symptom (cognitive decline) while ignoring the modifiable risk factor (untreated hearing loss) that preceded it by years. It’s analogous to waiting until someone has a heart attack to ask about their cholesterol and blood pressure, rather than addressing those factors decades earlier. The tradeoff is that seeking hearing evaluation and treatment requires acknowledging hearing loss as a problem—something many people resist due to stigma, cost, or simple denial—while medications are often prescribed without addressing upstream modifiable factors.
The Medication Trap: Why We’ve Been Looking in the Wrong Direction
The medical establishment has historically focused on developing medications to enhance cognitive function or slow the Alzheimer’s disease process directly, while overlooking the modifiable risk factors that could prevent cognitive decline from developing in the first place. This isn’t because medications are inherently more powerful than lifestyle and sensory interventions—it’s partly because medications are more profitable to develop and test, and partly because the evidence on modifiable risk factors is only now reaching critical mass.
A warning is warranted here: hearing loss treatment is not a cure-all, and it shouldn’t replace other important interventions like cardiovascular health, cognitive engagement, or social connection. However, the comparative evidence suggests that for someone with untreated hearing loss, getting hearing aids should be a higher priority than waiting for the next breakthrough dementia drug. If you have untreated hearing loss and are also taking a medication prescribed for cognitive health, you’re working against yourself—the medication is fighting an upstream problem while you continue to ignore a modifiable risk factor.
Real-World Implementation: The Difference Between “Getting” Hearing Aids and Actually Using Them
Having hearing aids and using them consistently are not the same thing. Some people get hearing aids and wear them sporadically because they feel uncomfortable, don’t help enough, or they’re inconsistent with their self-image. The cognitive benefits from the ACHIEVE study and Johns Hopkins research apply to consistent users, not to hearing aids sitting in a drawer.
Consider Derek, 68, who got hearing aids but wore them primarily when he knew he’d be in situations with difficult acoustics. His family noticed he was inconsistent: engaged and sharp in conversation when wearing them, noticeably foggy when he wasn’t. The cognitive protection requires the brain to work in a normalized acoustic environment regularly and consistently. If you’re considering hearing aids, the realistic question isn’t just whether they work—it’s whether you’ll actually wear them daily, and what support you need to make that adjustment successful.
The Future of Prevention: What Hearing Loss Detection Means for Brain Health
As the cognitive science community increasingly recognizes hearing loss as a major dementia risk factor, we’re likely to see a shift in preventive healthcare. Cognitive screening should begin with hearing evaluation. Dementia risk assessments should ask about untreated hearing loss. Neurologists should screen for hearing problems as readily as they screen for cardiovascular risk factors.
This isn’t futuristic thinking—it’s simply aligning our prevention strategy with the evidence. The broader insight is that brain health is not purely neurological. It’s sensory, it’s social, it’s connected to how well you can perceive and engage with the world around you. Hearing loss that goes untreated doesn’t just make the world quieter—it makes the brain work harder in ways that, over time, appear to accelerate aging. Treating it isn’t just about better hearing; it’s about cognitive preservation.
Conclusion
Hearing loss matters more than most medications for brain health because it’s common, modifiable, evidence-backed, and preventable in a way that few other dementia risk factors are. The research is substantial: a 2024 meta-analysis spanning 1.5 million people, the largest randomized trial on the topic showing 48% slowing of cognitive decline, and long-term follow-up studies demonstrating that treatment within 3 years of diagnosis provides superior protection. Yet it remains dramatically undertreated, partly because hearing loss carries social stigma and partly because we’ve been conditioned to look for pharmaceutical solutions rather than sensory ones.
If you have hearing loss, especially if you’re over 60, being screened for hearing loss and treating it should be as routine as checking your cholesterol or blood pressure. If someone you care for is showing early signs of cognitive decline, consider whether untreated hearing loss might be a contributing factor before focusing solely on cognitive interventions. The evidence suggests that hearing treatment might prevent cognitive decline from starting in the first place—and in medicine, prevention is always more effective than cure.
You Might Also Like
- Why treating hearing loss Matters More Than Medication for Brain Health
- Why treating sleep apnea Matters More Than Medication for Brain Health
- Why treating sleep apnea Matters More Than Medication for Brain Health
For more, see National Institute on Aging.
